Maven Securities’s AdaptHealth AHCO Stock Holding History

Maven Securities’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,000	Closed	-$186K	–	852
2023 Q1	$186K	Hold	15,000	–	–	﹤0.01%	886
2022 Q4	$288K	Hold	15,000	–	–	0.01%	711
2022 Q3	$282K	Sell	15,000 -30,000	-67%	-$617K	0.01%	953
2022 Q2	$812K	Hold	45,000	–	–	0.02%	422
2022 Q1	$721K	Buy	45,000 +10,000	+29%	+$180K	0.03%	432
2021 Q4	$856K	Sell	35,000 -49,572	-59%	-$1.16M	0.02%	397
2021 Q3	$1.97M	Buy	84,572 +49,572	+142%	+$1.2M	0.06%	251
2021 Q2	$969K	Sell	35,000 -265,000	-88%	-$7.56M	0.04%	455
2021 Q1	$10.9M	Sell	300,000 -515,199	-63%	-$18.2M	0.49%	28
2020 Q4	$30.9M	Buy	815,199 +481,705	+144%	+$14.9M	3.05%	1
2020 Q3	$7.27M	Buy	+333,494	New	+$7M	0.6%	33
2020 Q2	–	Sell	-112,711	Closed	-$1.22M	–	517
2020 Q1	$1.22M	Sell	112,711 -177,220	-61%	-$2.5M	0.15%	101
2019 Q4	$3.03M	Buy	+289,931	New	+$2.88M	0.27%	67

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Maven Securities's AHCO Position: Q2 2023 in Review

Maven Securities sold out of AdaptHealth (AHCO) in Q2 2023, closing a stake of 15,000 shares — an estimated $186K sold.

Maven Securities first reported a position in AHCO in Q4 2019 and held it in 13 quarters. The position peaked at $30.9M in Q4 2020. 182 funds tracked by Wall St. Rank hold AHCO as of Q2 2023.

Maven Securities reported no remaining AdaptHealth position as of Q2 2023 after selling out during the quarter.
Maven Securities sold 15,000 AdaptHealth shares in Q2 2023, an estimated $186K.
Maven Securities first reported a position in AdaptHealth in Q4 2019 and held it in 13 quarters.
Maven Securities's AdaptHealth position peaked at $30.9M in Q4 2020.
182 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2023.

Based on Maven Securities's 13F filing for Q2 2023, filed 4 Aug 2023.